Profile
Konstantina Katcheves is currently a Director at Mirati Therapeutics, Inc., Rayzebio, Inc., and Karuna Therapeutics, Inc.
Konstantina Katcheves active positions
| Companies | Position | Start |
|---|---|---|
| MIRATI THERAPEUTICS | Director/Board Member | 2024-01-22 |
| RAYZEBIO, INC. | Director/Board Member | 2024-02-25 |
| KARA THER | Director/Board Member | 2024-03-17 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RAYZEBIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Konstantina Katcheves
